Co-Diagnostics (NASDAQ: CODX) reported Q2 EPS of ($0.25), $0.09 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $2.66 million versus the consensus estimate of $375 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.